Table 2. Patient clinical characteristics stratified by Gleason score.
| ISUP grade group | Age | PSA | TPV | PZV | PZ-PSAD | TZ-PSAD | PSAD |
|---|---|---|---|---|---|---|---|
| 0 | 66.9±8.0 | 6.8±3.1 | 51.9±26.7 | 25.2±11.7 | 0.320±0.198 | 0.368±0.366 | 0.155±0.096 |
| 1 | 70.3±6.9 | 8.5±4.1 | 45.7±23.4 | 20.6±9.0 | 0.499±0.352 | 0.548±0.447 | 0.238±0.160 |
| 2 | 72.2±8.9 | 9.1±3.9 | 38.1±13.8 | 20.8±8.0 | 0.532±0.420 | 0.652±0.427 | 0.273±0.183 |
| 3 | 71.9±6.2 | 8.8±3.1 | 36.9±17.8 | 19.8±9.6 | 0.498±0.185 | 0.612±0.305 | 0.264±0.102 |
| 4 | 71.3±5.6 | 8.9±3.0 | 36.8±16.3 | 19.4±8.7 | 0.550±0.274 | 0.698±0.458 | 0.287±0.152 |
| 5 | 78.0±7.2 | 10.9±5.4 | 47.8±20.4 | 20.9±6.9 | 0.596±0.383 | 0.593±0.455 | 0.264±0.179 |
Data are shown as mean ± SD. ISUP, International Society of Urological Pathology; PSA, prostate-specific antigen; TPV, total prostate volume; PZV, peripheral zone volume; PZ-PSAD, peripheral zone prostate-specific antigen density; TZ-PSAD, transition zone prostate-specific antigen density.